![1]()
News
PIONEER-HF Extension: Don’t stall starting sacubitril/valsartan
April 14, 2019
NEW ORLEANS – “The early improvement in postdischarge outcomes supports the in-hospital initiation of sacubitril/valsartan.” – Dr. Adam D. DeVore
![1]()
Video
Highlights from the ‘Updates in ACS’ session (VIDEO)
April 12, 2019
HM19 attendees discuss the key lessons from the Updates in Acute Coronary Syndrome session.
![1]()
News
Clinicians, CMS confer over heart failure–readmission penalty
April 10, 2019
Evidence showed the CMS hospital penalty for excess heart failure readmissions has had unintended adverse consequences and needs fixing.
![1]()
News
One-dose-fits-all aspirin administration strategy may not be advisable
April 5, 2019
Are the same doses of aspirin equally effective in preventing cardiovascular (CV) events and long-term colorectal risk reduction in patients of various body sizes?
![1]()
News
30-day readmissions after STEMI with cardiogenic shock 13%
April 2, 2019
WASHINGTON – Risk factors for 30-day readmission included female sex, older age, and comorbidities.
![1]()
News
More chest compression–only CPR leads to increased survival rates
April 1, 2019
This alternative for bystanders raises both CPR performance rates and patient survival.
![1]()
News
Ticagrelor reversal agent looks promising
March 28, 2019
NEW ORLEANS – Ticagrelor’s antiplatelet effect was squelched within 5 minutes.
![1]()
News
Occurrence of pulmonary embolisms in hospitalized patients nearly doubled during 2004-2015
March 24, 2019
NEW ORLEANS – National Inpatient Sample data showed that during 2004-2015 hospitalized U.S. patients with a PE diagnosis jumped by 80%.
News
Intensive blood pressure lowering may not reduce risk of recurrent stroke
March 20, 2019
HONOLULU – Intensive treatment significantly reduces blood pressure, compared with standard treatment, and is equally safe.
![1]()
News
Andexanet alfa effectively reverses factor Xa inhibition
March 18, 2019
HONOLULU – The drug establishes good or excellent hemostasis in 82% of patients with acute major bleeding associated with factor Xa inhibition.
